Aon projects Asia Pacific medical cost inflation slowing to 9.7 percent
Aon plc (NYSE: AON) forecasts Asia-Pacific medical costs to rise 9.7% in 2027, down from 11.3% in 2026, outpacing general inflation. China and India see the largest declines, while Singapore and Taiwan see increases. Globally, medical trend rates are projected to decrease. Aon advises employers to manage costs using workforce and claims data. Chronic conditions drive claims, with cardiovascular disease leading. Wellness initiatives and plan design changes are top cost management strategies.
How this was made

The 30-second read
Why it matters
The 9.7% APAC medical cost inflation forecast for 2027 is the first public release of these numbers, offering fresh data for market participants.
Market read
The report influences health insurance pricing, employer benefit strategies, and could affect stock valuations of insurers and benefits providers.
What to watch
Potential policy changes in APAC countries and emerging telehealth adoption could further alter cost dynamics.
Background
Aon, a global professional services firm, regularly publishes medical cost trend reports used by employers and insurers for benefit planning.
Ticker impact
Aon plc released its 2027 Global Medical Trend Rates Report forecasting APAC medical cost inflation at 9.7% for 2027, a new data point for the insurer and benefits market.
likely pressure on health insurer equities as investors reassess cost assumptions.
The report is the first public disclosure of these specific APAC cost inflation numbers, providing fresh input for valuation models.
Market effects
Healthcare and benefits sectors may see earnings pressure as cost trends remain high despite moderation.
APAC employers and insurers may adjust benefit designs, affecting regional insurance stocks.
Provides a benchmark for global insurers and pension funds monitoring medical cost inflation.
Counterpoint
If cost growth slows more than expected, insurers could benefit from lower claim expenses.
Key entities
- companyAon plc
Global professional services firm publishing the medical cost trend report.

